LYTLE PAUL J 4
4 · PEREGRINE PHARMACEUTICALS INC · Filed Dec 28, 2012
Insider Transaction Report
Form 4
LYTLE PAUL J
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2012-12-27+200,000→ 807,500 totalExercise: $1.18From: 2013-03-27Exp: 2022-12-27→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option vests in eight (8) equal quarterly installments over a two (2) year period beginning March 27, 2013 and each quarter thereafter until fully-vested.